Alternative splicing in lung cancer

AO Coomer, F Black, A Greystoke, J Munkley… - … et Biophysica Acta (BBA …, 2019 - Elsevier
Lung cancer has the highest mortality rate of all cancers worldwide. Lung cancer is a very
heterogeneous disease that is often diagnosed at later stages which have a poor prognosis …

[HTML][HTML] Splice variants of the RTK family: their role in tumour progression and response to targeted therapy

C Abou-Fayçal, AS Hatat, S Gazzeri… - International journal of …, 2017 - mdpi.com
Receptor tyrosine kinases (RTKs) belong to a family of transmembrane receptors that
display tyrosine kinase activity and trigger the activation of downstream signalling pathways …

DIGGER: exploring the functional role of alternative splicing in protein interactions

Z Louadi, K Yuan, A Gress, O Tsoy… - Nucleic acids …, 2021 - academic.oup.com
Alternative splicing plays a major role in regulating the functional repertoire of the proteome.
However, isoform-specific effects to protein-protein interactions (PPIs) are usually …

Design and synthesis of certain 7-Aryl-2-Methyl-3-Substituted Pyrazolo {1, 5-a} Pyrimidines as multikinase inhibitors

MA Al-Qadhi, HA Allam, SH Fahim, TAA Yahya… - European journal of …, 2023 - Elsevier
Four new series 7a-e, 8a-e, 9a-e, and 10a-e of 7-aryl-3-substituted pyrazolo [1, 5-a]
pyrimidines were synthesized and tested for their RTK and STK inhibitory activity …

[HTML][HTML] Kinase inhibitor-responsive genotypes in EGFR mutated lung adenocarcinomas: moving past common point mutations or indels into uncommon kinase …

DB Costa - Translational lung cancer research, 2016 - ncbi.nlm.nih.gov
The most frequent epidermal growth factor receptor (EGFR) mutations found by traditional or
comprehensive molecular profiling of lung adenocarcinomas include indels of exon 19 (the …

Molecular characterization of genomic breakpoints of ALK rearrangements in non‐small cell lung cancer

Z Wang, Y Han, H Tao, M Xu, Z Liu, J Zhu… - Molecular …, 2023 - Wiley Online Library
ALK rearrangement is called the 'diamond mutation'in non‐small cell lung cancer (NSCLC).
Accurately identifying patients who are candidates for ALK inhibitors is a key step in making …

Phosphoproteomic profiling reveals ALK and MET as novel actionable targets across synovial sarcoma subtypes

EDG Fleuren, M Vlenterie, WTA Van Der Graaf… - Cancer Research, 2017 - AACR
Despite intensive multimodal treatment of sarcomas, a heterogeneous group of malignant
tumors arising from connective tissue, survival remains poor. Candidate-based targeted …

[HTML][HTML] Integrative splicing-quantitative-trait-locus analysis reveals risk loci for non-small-cell lung cancer

Y Wang, Y Ding, S Liu, C Wang, E Zhang… - The American Journal of …, 2023 - cell.com
Splicing quantitative trait loci (sQTLs) have been demonstrated to contribute to disease
etiology by affecting alternative splicing. However, the role of sQTLs in the development of …

De novo ALK kinase domain mutations are uncommon in kinase inhibitor-naïve ALK rearranged lung cancers

AR Lucena-Araujo, JP Moran, PA VanderLaan… - Lung Cancer, 2016 - Elsevier
Introduction Anaplastic lymphoma kinase (ALK) rearranged lung adenocarcinomas are
responsive to the multitargeted ALK inhibitor crizotinib. One of the common mechanisms of …

Angiopoietin-Related Protein 4-Transcript 3 Increases the Proliferation, Invasion, and Migration of Hepatocellular Carcinoma Cells and Inhibits Apoptosis

Y Bai, G Cui, X Sun, M Wei, Y Liu, J Guo… - DNA and Cell …, 2024 - liebertpub.com
To investigate the functional differences of angiopoietin-related protein 4 (ANGPTL4)
transcripts in hepatocellular carcinoma (HCC) cells. By transfecting ANGPTL4-Transcript 1 …